The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

Menopausal hormonal therapy, including estrogen alone and estrogen combined with progesterone, has been prescribed to help ...

Menopause used to be a taboo topic in many quarters. Now, it’s frequently in the news. In March 2024, the White House announced an initiative to “Galvanize New Research on Women’s Midlife Health.” In ...

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.

FDA Commissioner Marty Makary, MD, MPH, announced that George Tidmarsh, MD, PhD, a cancer and pediatric specialist, will ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.